As CBS News reported, one such reversal includes patents held by Myriad Genetics Inc. on a breast cancer test recently brought into the spotlight by actress Angelina Jolie, who had a double mastectomy because of one of the genes involved in this case.
"We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," Thomas said.